Sensus Healthcare, Inc. (SRTS) 10-Year Financial Performance & Capital Metrics

SRTS • • Industrial / General

HealthcareMedical DevicesOncology & Cancer Treatment DevicesRadiation Therapy Systems

AboutSensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.Show more

Revenue $42M +71.3%
EBITDA $9M +10687.3%
Net Income $7M +1270.5%
EPS (Diluted) 0.41 +1275.8%
Gross Margin 58.44% +1.4%
EBITDA Margin 20.38% +6197.2%
Operating Margin 19.35% +1336.2%
Net Margin 15.9% +700.0%
ROE 12.7% +1169.0%
ROIC 19.94% +1841.9%
Debt/Equity 0.01 -32.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 26.4%
✓Trading at only 1.5x book value

✗Weaknesses

✗Negative free cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y21.82%

5Y8.93%

3Y15.63%

TTM-13.79%

Profit (Net Income) CAGR

10Y-

5Y-

3Y17.29%

TTM-132.28%

EPS CAGR

10Y-

5Y-

3Y17.93%

TTM-132.46%

ROCE

10Y Avg-1.25%

5Y Avg7.97%

3Y Avg17.97%

Latest15.3%

Peer Comparison

Radiation Therapy Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
SRTSSensus Healthcare, Inc.	81.47M	4.96	12.10	71.31%	-8.44%	-5.87%	0.01
CATXPerspective Therapeutics, Inc.	184.36M	2.48	-2.02	-100%	-197.29%	-42.77%	0.01
TLSITriSalus Life Sciences, Inc.	307.28M	6.15	-4.92	58.99%	-98.45%
PROFProfound Medical Corp.	302.68M	8.34	-7.79	41.23%	-272.77%	-130.59%	0.08
DCTHDelcath Systems, Inc.	354.29M	10.21	-11.03	17.02%	1.5%	1.04%	0.02
PTHLPheton Holdings Ltd Class A Ordinary Shares	8.46M	0.90	-17.38	-28.7%	-91.16%	-13.91%	0.04
ARAYAccuray Incorporated	98.61M	0.87	-56.13	2.68%	-4.28%	-31.22%	2.17

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	10.27M	14.81M	20.59M	26.43M	27.26M	9.58M	27.04M	44.53M	24.41M	41.81M
Revenue Growth %	0.77%	0.44%	0.39%	0.28%	0.03%	-0.65%	1.82%	0.65%	-0.45%	0.71%
Cost of Goods Sold+	3.7M	4.97M	6.79M	9.52M	9.71M	4.33M	10.05M	14.9M	10.35M	17.38M
COGS % of Revenue	0.36%	0.34%	0.33%	0.36%	0.36%	0.45%	0.37%	0.33%	0.42%	0.42%
Gross Profit+	6.57M	9.85M	13.8M	16.91M	17.56M	5.25M	16.99M	29.63M	14.06M	24.43M
Gross Margin %	0.64%	0.66%	0.67%	0.64%	0.64%	0.55%	0.63%	0.67%	0.58%	0.58%
Gross Profit Growth %	0.75%	0.5%	0.4%	0.23%	0.04%	-0.7%	2.24%	0.74%	-0.53%	0.74%
Operating Expenses+	6.8M	10.21M	17.52M	18.92M	19.53M	13.48M	12.87M	14.8M	14.44M	16.34M
OpEx % of Revenue	0.66%	0.69%	0.85%	0.72%	0.72%	1.41%	0.48%	0.33%	0.59%	0.39%
Selling, General & Admin	5.33M	8.38M	12.03M	12.66M	13.11M	9.32M	9.43M	11.34M	10.76M	12.13M
SG&A % of Revenue	0.52%	0.57%	0.58%	0.48%	0.48%	0.97%	0.35%	0.25%	0.44%	0.29%
Research & Development	1.47M	1.82M	5.49M	6.26M	6.42M	4.16M	3.44M	3.46M	3.68M	4.22M
R&D % of Revenue	0.14%	0.12%	0.27%	0.24%	0.24%	0.43%	0.13%	0.08%	0.15%	0.1%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-221.26K	-363.12K	-3.72M	-2.01M	-1.97M	-8.23M	4.12M	14.83M	-382K	8.09M
Operating Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.07%	-0.86%	0.15%	0.33%	-0.02%	0.19%
Operating Income Growth %	0.94%	-0.64%	-9.24%	0.46%	0.02%	-3.18%	1.5%	2.6%	-1.03%	22.18%
EBITDA+	94.34K	-25.54K	-3.33M	-1.35M	-1.42M	-7.51M	4.73M	15.34M	79K	8.52M
EBITDA Margin %	0.01%	-0%	-0.16%	-0.05%	-0.05%	-0.78%	0.18%	0.34%	0%	0.2%
EBITDA Growth %	1.03%	-1.27%	-129.39%	0.6%	-0.06%	-4.28%	1.63%	2.24%	-0.99%	106.87%
D&A (Non-Cash Add-back)	315.6K	337.58K	387.92K	658.25K	545.72K	722K	613K	509K	461K	432K
EBIT	-219.48K	-324.58K	-3.64M	-1.87M	-1.7M	-6.82M	4.12M	14.83M	-382K	8.09M
Net Interest Income+	-16.01K	16.67K	6.93K	-17.41K	268.29K	52K	1K	380K	992K	932K
Interest Income	1.78K	38.54K	75.81K	139.28K	268.29K	66K	2K	382K	992K	932K
Interest Expense	17.79K	21.87K	68.88K	156.69K	0	14K	1K	2K	0	0
Other Income/Expense	-16.01K	16.67K	6.93K	-17.41K	268.29K	1.4M	-1K	13.16M	1.03M	932K
Pretax Income+	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	27.99M	652K	9.02M
Pretax Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.06%	-0.71%	0.15%	0.63%	0.03%	0.22%
Income Tax+	1.78K	0	0	0	0	0	0	3.75M	167K	2.38M
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	0.87%	0.74%	0.74%
Net Income+	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Net Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.06%	-0.71%	0.15%	0.54%	0.02%	0.16%
Net Income Growth %	0.94%	-0.46%	-9.71%	0.45%	0.16%	-3.02%	1.6%	4.89%	-0.98%	12.71%
Net Income (Continuing)	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.02	-0.03	-0.28	-0.14	-0.07	-0.42	0.25	1.46	0.03	0.41
EPS Growth %	0.94%	-0.31%	-8.72%	0.5%	0.49%	-4.91%	1.6%	4.84%	-0.98%	12.76%
EPS (Basic)	-0.02	-0.03	-0.28	-0.14	-0.07	-0.42	0.25	1.47	0.03	0.41
Diluted Shares Outstanding	10.78M	12.03M	13.24M	14.12M	16.23M	16.43M	16.5M	16.62M	16.27M	16.36M
Basic Shares Outstanding	10.78M	12.03M	13.24M	14.12M	16.23M	16.43M	16.48M	16.48M	16.26M	16.31M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	8.57M	16.76M	17.89M	31.9M	34M	25.17M	31.25M	53.24M	49.53M	56.74M
Cash & Short-Term Investments	5.07M	11.5M	11.19M	15.38M	15.49M	14.91M	14.52M	25.52M	23.15M	22.06M
Cash Only	5.07M	5.04M	10.09M	12.48M	8.1M	14.91M	14.52M	25.52M	23.15M	22.06M
Short-Term Investments	0	6.46M	1.1M	2.89M	7.39M	0	0	0	0	0
Accounts Receivable	2.07M	3.1M	4.96M	13.15M	14.01M	3.78M	12.13M	17.3M	10.64M	19.73M
Days Sales Outstanding	73.6	76.36	87.9	181.57	187.58	143.91	163.72	141.79	159.21	172.26
Inventory	998.86K	1.25M	1.17M	1.63M	3M	4.43M	1.76M	3.5M	11.86M	10.1M
Days Inventory Outstanding	98.57	92.25	62.99	62.47	112.71	373.35	63.86	85.74	418.49	212.1
Other Current Assets	310K	0	0	0	0	0	268K	660K	888K	1.51M
Total Non-Current Assets+	1.07M	2.19M	948.47K	1.35M	2.92M	2.84M	995K	3.49M	4.18M	5.43M
Property, Plant & Equipment	320.7K	433.41K	394.08K	891.03K	2.48M	2.43M	774K	1.24M	1.24M	2.58M
Fixed Asset Turnover	32.03x	34.17x	52.24x	29.66x	10.98x	3.94x	34.94x	35.94x	19.71x	16.22x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	722.89K	626.51K	530.12K	433.74K	337.35K	338K	146K	50K	0	0
Long-Term Investments	0	1.1M	0	0	0	0	0	0	0	0
Other Non-Current Assets	24.27K	24.27K	24.27K	24.27K	101.56K	69K	75K	492K	804K	652K
Total Assets+	9.64M	18.95M	18.84M	33.25M	36.92M	28.01M	32.24M	56.73M	53.71M	62.16M
Asset Turnover	1.07x	0.78x	1.09x	0.79x	0.74x	0.34x	0.84x	0.78x	0.45x	0.67x
Asset Growth %	0.39%	0.97%	-0.01%	0.77%	0.11%	-0.24%	0.15%	0.76%	-0.05%	0.16%
Total Current Liabilities+	3.67M	3.66M	7.08M	6.02M	6.47M	4.86M	5.96M	7.7M	4.21M	5.88M
Accounts Payable	2.31M	2.76M	4.07M	5.17M	0	0	4.06M	5.52M	2.79M	4.81M
Days Payables Outstanding	227.71	203.06	218.74	198.15	-	-	147.32	135.21	98.54	101.06
Short-Term Debt	422.7K	0	0	0	0	0	51K	0	0	0
Deferred Revenue (Current)	890.23K	853.8K	652.24K	722.02K	1000K	1000K	1000K	693K	657K	541K
Other Current Liabilities	48.36K	40.48K	146.72K	136.22K	4.97M	3.06M	508K	403K	538K	329K
Current Ratio	2.34x	4.58x	2.53x	5.30x	5.26x	5.18x	5.24x	6.92x	11.76x	9.64x
Quick Ratio	2.06x	4.24x	2.36x	5.03x	4.79x	4.27x	4.94x	6.46x	8.94x	7.93x
Cash Conversion Cycle	-55.54	-34.45	-67.85	45.89	-	-	80.26	92.32	479.15	283.3
Total Non-Current Liabilities+	45.79K	16.25K	73.08K	766.73K	2.45M	1.66M	262K	969K	656K	453K
Long-Term Debt	0	0	2.21M	0	0	267K	0	0	0	0
Capital Lease Obligations	0	0	0	0	1.12M	812K	0	830K	596K	398K
Deferred Tax Liabilities	0	0	-4.43M	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	3.71M	3.67M	7.15M	6.79M	8.92M	6.51M	6.22M	8.67M	4.87M	6.34M
Total Debt+	422.7K	0	2.21M	0	1.43M	1.38M	225K	1.02M	783K	602K
Net Debt	-4.64M	-5.04M	-7.87M	-12.48M	-6.68M	-13.53M	-14.29M	-24.5M	-22.36M	-21.45M
Debt / Equity	0.07x	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x
Debt / EBITDA	4.48x	-	-	-	-	-	0.05x	0.07x	9.91x	0.07x
Net Debt / EBITDA	-49.21x	-	-	-	-	-	-3.02x	-1.60x	-283.10x	-2.52x
Interest Coverage	-12.44x	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-
Total Equity+	5.92M	15.27M	11.68M	26.46M	28M	21.5M	26.02M	48.07M	48.84M	55.83M
Equity Growth %	0.43%	1.58%	-0.24%	1.27%	0.06%	-0.23%	0.21%	0.85%	0.02%	0.14%
Book Value per Share	0.55	1.27	0.88	1.87	1.72	1.31	1.58	2.89	3.00	3.41
Total Shareholders' Equity	5.92M	15.27M	11.68M	26.46M	28M	21.5M	26.02M	48.07M	48.84M	55.83M
Common Stock	428	135.46K	135.22K	161.46K	165.4K	166K	167K	169K	169K	169K
Retained Earnings	-7.45M	-7.79M	-11.5M	-13.53M	-15.23M	-22.06M	-17.94M	6.3M	6.79M	13.43M
Treasury Stock	0	0	-133.82K	-133.82K	-252.57K	-310K	-325K	-3.43M	-3.52M	-3.57M
Accumulated OCI	-669.86K	-587.17K	-514.13K	-858.01K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.34M	-851.02K	-3.06M	-8.56M	-2.11M	-434.18K	-286K	-1.41M	-2.15M	-831K
Operating CF Margin %	-0.13%	-0.06%	-0.15%	-0.32%	-0.08%	-0.05%	-0.01%	-0.03%	-0.09%	-0.02%
Operating CF Growth %	0.28%	0.36%	-2.59%	-1.8%	0.75%	0.79%	0.34%	-3.94%	-0.52%	0.61%
Net Income	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Depreciation & Amortization	315.6K	337.58K	387.92K	658.25K	545.72K	721.87K	613K	509K	461K	432K
Stock-Based Compensation	6.48K	726.38K	405.9K	982.62K	0	0	415K	187K	328K	323K
Deferred Taxes	0	0	0	0	0	0	0	-1.71M	-427K	-57K
Other Non-Cash Items	34.5K	3.03M	428.95K	108.53K	1.35M	118.21K	705K	-11.71M	568K	378K
Working Capital Changes	-1.46M	-4.6M	-568.86K	-8.29M	-2.3M	5.56M	-6.14M	-12.92M	-3.56M	-8.55M
Change in Receivables	-1.66M	-1.03M	-2.05M	-8.17M	-1.22M	10.25M	-8.43M	-5.31M	6.65M	-9.21M
Change in Inventory	-288.39K	-3.32M	118.92K	-661.42K	-1.7M	-1.43M	2.73M	-3.19M	-8.58M	268K
Change in Payables	0	0	0	0	-676.56K	-2.3M	962K	799K	-2.73M	2.02M
Cash from Investing+	-196.19K	-7.85M	6.17M	-2.64M	-4.9M	7.03M	129K	14.84M	-187K	-276K
Capital Expenditures	-196.19K	-286K	-287.59K	-854.83K	-400.59K	-358.55K	-128K	-159K	-229K	-276K
CapEx % of Revenue	0.02%	0.02%	0.01%	0.03%	0.01%	0.04%	0%	0%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-7.85M	6.46M	-2.64B	0	0	0	0	42K	0
Cash from Financing+	2.06M	8.68M	1.93M	13.6M	2.62M	210.01K	-231K	-2.43M	-40K	15K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-2.55M	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-185.81K	-994.02K	-289.29K	-1.43M	-118.75K	-57.33K	0	622K	-13K	-52K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-1.54M	-1.14M	-3.34M	-9.42M	-2.51M	-792.72K	-414K	-1.57M	-2.37M	-1.11M
FCF Margin %	-0.15%	-0.08%	-0.16%	-0.36%	-0.09%	-0.08%	-0.02%	-0.04%	-0.1%	-0.03%
FCF Growth %	0.23%	0.26%	-1.94%	-1.82%	0.73%	0.68%	0.48%	-2.79%	-0.51%	0.53%
FCF per Share	-0.14	-0.09	-0.25	-0.67	-0.15	-0.05	-0.03	-0.09	-0.15	-0.07
FCF Conversion (FCF/Net Income)	5.64x	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x
Interest Paid	0	0	0	0	0	0	0	2K	0	0
Taxes Paid	0	0	0	0	0	0	0	4.57M	1.44M	2.58M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-4.72%	-3.27%	-27.53%	-10.61%	-6.24%	-27.62%	17.34%	65.45%	1%	12.7%
Return on Invested Capital (ROIC)	-26.47%	-4.73%	-39.71%	-16.91%	-8.36%	-42.16%	31.38%	63.04%	-1.14%	19.94%
Gross Margin	64%	66.48%	67.03%	63.99%	64.4%	54.81%	62.82%	66.53%	57.61%	58.44%
Net Margin	-2.31%	-2.34%	-18.02%	-7.65%	-6.24%	-71.38%	15.23%	54.44%	1.99%	15.9%
Debt / Equity	0.07x	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x
Interest Coverage	-12.44x	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-
FCF Conversion	5.64x	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x
Revenue Growth	76.81%	44.17%	39%	28.36%	3.16%	-64.87%	182.36%	64.68%	-45.2%	71.31%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Product	24.65M	25.11M	5.45M	23K	1.01M	20.35M	36.4M
Product Growth	-	1.86%	-78.30%	-99.58%	4313.04%	1904.63%	78.89%
Service Revenue	-	-	-	-	-	-	3.2M
Service Revenue Growth	-	-	-	-	-	-	-
Service	1.78M	2.15M	4.13M	3.11M	3.17M	2.8M	1.96M
Service Growth	-	21.28%	91.62%	-24.58%	1.96%	-11.88%	-29.89%
Product Revenue	-	-	-	-	-	-	247K
Product Revenue Growth	-	-	-	-	-	-	-

Revenue by Geography

	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	41.98M	22.28M	40.18M
UNITED STATES Growth	-	-	-	-	-	-46.92%	80.35%
CHINA	-	-	-	-	2.45M	1.49M	1.45M
CHINA Growth	-	-	-	-	-	-39.19%	-3.09%
ISRAEL	-	-	-	-	-	-	172K
ISRAEL Growth	-	-	-	-	-	-	-
Other	-	-	-	-	-	-	10K
Other Growth	-	-	-	-	-	-	-
GUATEMALA	-	-	-	-	-	190K	-
GUATEMALA Growth	-	-	-	-	-	-	-
IRELAND	-	-	-	-	-	135K	-
IRELAND Growth	-	-	-	-	-	-	-
Other Member	-	-	-	-	104K	45K	-
Other Member Growth	-	-	-	-	-	-56.73%	-

Frequently Asked Questions

Valuation & Price

Sensus Healthcare, Inc. (SRTS) has a price-to-earnings (P/E) ratio of 12.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Sensus Healthcare, Inc. (SRTS) reported $35.6M in revenue for fiscal year 2024. This represents a 513% increase from $5.8M in 2014.

Sensus Healthcare, Inc. (SRTS) grew revenue by 71.3% over the past year. This is strong growth.

Sensus Healthcare, Inc. (SRTS) reported a net loss of $3.0M for fiscal year 2024.

Dividend & Returns

Sensus Healthcare, Inc. (SRTS) has a return on equity (ROE) of 12.7%. This is reasonable for most industries.

Sensus Healthcare, Inc. (SRTS) had negative free cash flow of $0.1M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Sensus Healthcare, Inc. (SRTS) 10-Year Financial Performance & Capital Metrics

SRTS • • Industrial / General

HealthcareMedical DevicesOncology & Cancer Treatment DevicesRadiation Therapy Systems

Revenue $42M +71.3%
EBITDA $9M +10687.3%
Net Income $7M +1270.5%
EPS (Diluted) 0.41 +1275.8%
Gross Margin 58.44% +1.4%
EBITDA Margin 20.38% +6197.2%
Operating Margin 19.35% +1336.2%
Net Margin 15.9% +700.0%
ROE 12.7% +1169.0%
ROIC 19.94% +1841.9%
Debt/Equity 0.01 -32.7%
Interest Coverage -

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 26.4%
✓Trading at only 1.5x book value

✗Weaknesses

✗Negative free cash flow
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y21.82%

5Y8.93%

3Y15.63%

TTM-13.79%

Profit (Net Income) CAGR

10Y-

5Y-

3Y17.29%

TTM-132.28%

EPS CAGR

10Y-

5Y-

3Y17.93%

TTM-132.46%

ROCE

10Y Avg-1.25%

5Y Avg7.97%

3Y Avg17.97%

Latest15.3%

Peer Comparison

Radiation Therapy Systems

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
SRTSSensus Healthcare, Inc.	81.47M	4.96	12.10	71.31%	-8.44%	-5.87%	0.01
CATXPerspective Therapeutics, Inc.	184.36M	2.48	-2.02	-100%	-197.29%	-42.77%	0.01
TLSITriSalus Life Sciences, Inc.	307.28M	6.15	-4.92	58.99%	-98.45%
PROFProfound Medical Corp.	302.68M	8.34	-7.79	41.23%	-272.77%	-130.59%	0.08
DCTHDelcath Systems, Inc.	354.29M	10.21	-11.03	17.02%	1.5%	1.04%	0.02
PTHLPheton Holdings Ltd Class A Ordinary Shares	8.46M	0.90	-17.38	-28.7%	-91.16%	-13.91%	0.04
ARAYAccuray Incorporated	98.61M	0.87	-56.13	2.68%	-4.28%	-31.22%	2.17

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	10.27M	14.81M	20.59M	26.43M	27.26M	9.58M	27.04M	44.53M	24.41M	41.81M
Revenue Growth %	0.77%	0.44%	0.39%	0.28%	0.03%	-0.65%	1.82%	0.65%	-0.45%	0.71%
Cost of Goods Sold+	3.7M	4.97M	6.79M	9.52M	9.71M	4.33M	10.05M	14.9M	10.35M	17.38M
COGS % of Revenue	0.36%	0.34%	0.33%	0.36%	0.36%	0.45%	0.37%	0.33%	0.42%	0.42%
Gross Profit+	6.57M	9.85M	13.8M	16.91M	17.56M	5.25M	16.99M	29.63M	14.06M	24.43M
Gross Margin %	0.64%	0.66%	0.67%	0.64%	0.64%	0.55%	0.63%	0.67%	0.58%	0.58%
Gross Profit Growth %	0.75%	0.5%	0.4%	0.23%	0.04%	-0.7%	2.24%	0.74%	-0.53%	0.74%
Operating Expenses+	6.8M	10.21M	17.52M	18.92M	19.53M	13.48M	12.87M	14.8M	14.44M	16.34M
OpEx % of Revenue	0.66%	0.69%	0.85%	0.72%	0.72%	1.41%	0.48%	0.33%	0.59%	0.39%
Selling, General & Admin	5.33M	8.38M	12.03M	12.66M	13.11M	9.32M	9.43M	11.34M	10.76M	12.13M
SG&A % of Revenue	0.52%	0.57%	0.58%	0.48%	0.48%	0.97%	0.35%	0.25%	0.44%	0.29%
Research & Development	1.47M	1.82M	5.49M	6.26M	6.42M	4.16M	3.44M	3.46M	3.68M	4.22M
R&D % of Revenue	0.14%	0.12%	0.27%	0.24%	0.24%	0.43%	0.13%	0.08%	0.15%	0.1%
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0
Operating Income+	-221.26K	-363.12K	-3.72M	-2.01M	-1.97M	-8.23M	4.12M	14.83M	-382K	8.09M
Operating Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.07%	-0.86%	0.15%	0.33%	-0.02%	0.19%
Operating Income Growth %	0.94%	-0.64%	-9.24%	0.46%	0.02%	-3.18%	1.5%	2.6%	-1.03%	22.18%
EBITDA+	94.34K	-25.54K	-3.33M	-1.35M	-1.42M	-7.51M	4.73M	15.34M	79K	8.52M
EBITDA Margin %	0.01%	-0%	-0.16%	-0.05%	-0.05%	-0.78%	0.18%	0.34%	0%	0.2%
EBITDA Growth %	1.03%	-1.27%	-129.39%	0.6%	-0.06%	-4.28%	1.63%	2.24%	-0.99%	106.87%
D&A (Non-Cash Add-back)	315.6K	337.58K	387.92K	658.25K	545.72K	722K	613K	509K	461K	432K
EBIT	-219.48K	-324.58K	-3.64M	-1.87M	-1.7M	-6.82M	4.12M	14.83M	-382K	8.09M
Net Interest Income+	-16.01K	16.67K	6.93K	-17.41K	268.29K	52K	1K	380K	992K	932K
Interest Income	1.78K	38.54K	75.81K	139.28K	268.29K	66K	2K	382K	992K	932K
Interest Expense	17.79K	21.87K	68.88K	156.69K	0	14K	1K	2K	0	0
Other Income/Expense	-16.01K	16.67K	6.93K	-17.41K	268.29K	1.4M	-1K	13.16M	1.03M	932K
Pretax Income+	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	27.99M	652K	9.02M
Pretax Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.06%	-0.71%	0.15%	0.63%	0.03%	0.22%
Income Tax+	1.78K	0	0	0	0	0	0	3.75M	167K	2.38M
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	0.87%	0.74%	0.74%
Net Income+	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Net Margin %	-0.02%	-0.02%	-0.18%	-0.08%	-0.06%	-0.71%	0.15%	0.54%	0.02%	0.16%
Net Income Growth %	0.94%	-0.46%	-9.71%	0.45%	0.16%	-3.02%	1.6%	4.89%	-0.98%	12.71%
Net Income (Continuing)	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-0.02	-0.03	-0.28	-0.14	-0.07	-0.42	0.25	1.46	0.03	0.41
EPS Growth %	0.94%	-0.31%	-8.72%	0.5%	0.49%	-4.91%	1.6%	4.84%	-0.98%	12.76%
EPS (Basic)	-0.02	-0.03	-0.28	-0.14	-0.07	-0.42	0.25	1.47	0.03	0.41
Diluted Shares Outstanding	10.78M	12.03M	13.24M	14.12M	16.23M	16.43M	16.5M	16.62M	16.27M	16.36M
Basic Shares Outstanding	10.78M	12.03M	13.24M	14.12M	16.23M	16.43M	16.48M	16.48M	16.26M	16.31M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	8.57M	16.76M	17.89M	31.9M	34M	25.17M	31.25M	53.24M	49.53M	56.74M
Cash & Short-Term Investments	5.07M	11.5M	11.19M	15.38M	15.49M	14.91M	14.52M	25.52M	23.15M	22.06M
Cash Only	5.07M	5.04M	10.09M	12.48M	8.1M	14.91M	14.52M	25.52M	23.15M	22.06M
Short-Term Investments	0	6.46M	1.1M	2.89M	7.39M	0	0	0	0	0
Accounts Receivable	2.07M	3.1M	4.96M	13.15M	14.01M	3.78M	12.13M	17.3M	10.64M	19.73M
Days Sales Outstanding	73.6	76.36	87.9	181.57	187.58	143.91	163.72	141.79	159.21	172.26
Inventory	998.86K	1.25M	1.17M	1.63M	3M	4.43M	1.76M	3.5M	11.86M	10.1M
Days Inventory Outstanding	98.57	92.25	62.99	62.47	112.71	373.35	63.86	85.74	418.49	212.1
Other Current Assets	310K	0	0	0	0	0	268K	660K	888K	1.51M
Total Non-Current Assets+	1.07M	2.19M	948.47K	1.35M	2.92M	2.84M	995K	3.49M	4.18M	5.43M
Property, Plant & Equipment	320.7K	433.41K	394.08K	891.03K	2.48M	2.43M	774K	1.24M	1.24M	2.58M
Fixed Asset Turnover	32.03x	34.17x	52.24x	29.66x	10.98x	3.94x	34.94x	35.94x	19.71x	16.22x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	722.89K	626.51K	530.12K	433.74K	337.35K	338K	146K	50K	0	0
Long-Term Investments	0	1.1M	0	0	0	0	0	0	0	0
Other Non-Current Assets	24.27K	24.27K	24.27K	24.27K	101.56K	69K	75K	492K	804K	652K
Total Assets+	9.64M	18.95M	18.84M	33.25M	36.92M	28.01M	32.24M	56.73M	53.71M	62.16M
Asset Turnover	1.07x	0.78x	1.09x	0.79x	0.74x	0.34x	0.84x	0.78x	0.45x	0.67x
Asset Growth %	0.39%	0.97%	-0.01%	0.77%	0.11%	-0.24%	0.15%	0.76%	-0.05%	0.16%
Total Current Liabilities+	3.67M	3.66M	7.08M	6.02M	6.47M	4.86M	5.96M	7.7M	4.21M	5.88M
Accounts Payable	2.31M	2.76M	4.07M	5.17M	0	0	4.06M	5.52M	2.79M	4.81M
Days Payables Outstanding	227.71	203.06	218.74	198.15	-	-	147.32	135.21	98.54	101.06
Short-Term Debt	422.7K	0	0	0	0	0	51K	0	0	0
Deferred Revenue (Current)	890.23K	853.8K	652.24K	722.02K	1000K	1000K	1000K	693K	657K	541K
Other Current Liabilities	48.36K	40.48K	146.72K	136.22K	4.97M	3.06M	508K	403K	538K	329K
Current Ratio	2.34x	4.58x	2.53x	5.30x	5.26x	5.18x	5.24x	6.92x	11.76x	9.64x
Quick Ratio	2.06x	4.24x	2.36x	5.03x	4.79x	4.27x	4.94x	6.46x	8.94x	7.93x
Cash Conversion Cycle	-55.54	-34.45	-67.85	45.89	-	-	80.26	92.32	479.15	283.3
Total Non-Current Liabilities+	45.79K	16.25K	73.08K	766.73K	2.45M	1.66M	262K	969K	656K	453K
Long-Term Debt	0	0	2.21M	0	0	267K	0	0	0	0
Capital Lease Obligations	0	0	0	0	1.12M	812K	0	830K	596K	398K
Deferred Tax Liabilities	0	0	-4.43M	0	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	0	0	0	0	0	0	0
Total Liabilities	3.71M	3.67M	7.15M	6.79M	8.92M	6.51M	6.22M	8.67M	4.87M	6.34M
Total Debt+	422.7K	0	2.21M	0	1.43M	1.38M	225K	1.02M	783K	602K
Net Debt	-4.64M	-5.04M	-7.87M	-12.48M	-6.68M	-13.53M	-14.29M	-24.5M	-22.36M	-21.45M
Debt / Equity	0.07x	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x
Debt / EBITDA	4.48x	-	-	-	-	-	0.05x	0.07x	9.91x	0.07x
Net Debt / EBITDA	-49.21x	-	-	-	-	-	-3.02x	-1.60x	-283.10x	-2.52x
Interest Coverage	-12.44x	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-
Total Equity+	5.92M	15.27M	11.68M	26.46M	28M	21.5M	26.02M	48.07M	48.84M	55.83M
Equity Growth %	0.43%	1.58%	-0.24%	1.27%	0.06%	-0.23%	0.21%	0.85%	0.02%	0.14%
Book Value per Share	0.55	1.27	0.88	1.87	1.72	1.31	1.58	2.89	3.00	3.41
Total Shareholders' Equity	5.92M	15.27M	11.68M	26.46M	28M	21.5M	26.02M	48.07M	48.84M	55.83M
Common Stock	428	135.46K	135.22K	161.46K	165.4K	166K	167K	169K	169K	169K
Retained Earnings	-7.45M	-7.79M	-11.5M	-13.53M	-15.23M	-22.06M	-17.94M	6.3M	6.79M	13.43M
Treasury Stock	0	0	-133.82K	-133.82K	-252.57K	-310K	-325K	-3.43M	-3.52M	-3.57M
Accumulated OCI	-669.86K	-587.17K	-514.13K	-858.01K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-1.34M	-851.02K	-3.06M	-8.56M	-2.11M	-434.18K	-286K	-1.41M	-2.15M	-831K
Operating CF Margin %	-0.13%	-0.06%	-0.15%	-0.32%	-0.08%	-0.05%	-0.01%	-0.03%	-0.09%	-0.02%
Operating CF Growth %	0.28%	0.36%	-2.59%	-1.8%	0.75%	0.79%	0.34%	-3.94%	-0.52%	0.61%
Net Income	-237.27K	-346.45K	-3.71M	-2.02M	-1.7M	-6.84M	4.12M	24.24M	485K	6.65M
Depreciation & Amortization	315.6K	337.58K	387.92K	658.25K	545.72K	721.87K	613K	509K	461K	432K
Stock-Based Compensation	6.48K	726.38K	405.9K	982.62K	0	0	415K	187K	328K	323K
Deferred Taxes	0	0	0	0	0	0	0	-1.71M	-427K	-57K
Other Non-Cash Items	34.5K	3.03M	428.95K	108.53K	1.35M	118.21K	705K	-11.71M	568K	378K
Working Capital Changes	-1.46M	-4.6M	-568.86K	-8.29M	-2.3M	5.56M	-6.14M	-12.92M	-3.56M	-8.55M
Change in Receivables	-1.66M	-1.03M	-2.05M	-8.17M	-1.22M	10.25M	-8.43M	-5.31M	6.65M	-9.21M
Change in Inventory	-288.39K	-3.32M	118.92K	-661.42K	-1.7M	-1.43M	2.73M	-3.19M	-8.58M	268K
Change in Payables	0	0	0	0	-676.56K	-2.3M	962K	799K	-2.73M	2.02M
Cash from Investing+	-196.19K	-7.85M	6.17M	-2.64M	-4.9M	7.03M	129K	14.84M	-187K	-276K
Capital Expenditures	-196.19K	-286K	-287.59K	-854.83K	-400.59K	-358.55K	-128K	-159K	-229K	-276K
CapEx % of Revenue	0.02%	0.02%	0.01%	0.03%	0.01%	0.04%	0%	0%	0.01%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	0	-7.85M	6.46M	-2.64B	0	0	0	0	42K	0
Cash from Financing+	2.06M	8.68M	1.93M	13.6M	2.62M	210.01K	-231K	-2.43M	-40K	15K
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	-2.55M	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-185.81K	-994.02K	-289.29K	-1.43M	-118.75K	-57.33K	0	622K	-13K	-52K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-1.54M	-1.14M	-3.34M	-9.42M	-2.51M	-792.72K	-414K	-1.57M	-2.37M	-1.11M
FCF Margin %	-0.15%	-0.08%	-0.16%	-0.36%	-0.09%	-0.08%	-0.02%	-0.04%	-0.1%	-0.03%
FCF Growth %	0.23%	0.26%	-1.94%	-1.82%	0.73%	0.68%	0.48%	-2.79%	-0.51%	0.53%
FCF per Share	-0.14	-0.09	-0.25	-0.67	-0.15	-0.05	-0.03	-0.09	-0.15	-0.07
FCF Conversion (FCF/Net Income)	5.64x	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x
Interest Paid	0	0	0	0	0	0	0	2K	0	0
Taxes Paid	0	0	0	0	0	0	0	4.57M	1.44M	2.58M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-4.72%	-3.27%	-27.53%	-10.61%	-6.24%	-27.62%	17.34%	65.45%	1%	12.7%
Return on Invested Capital (ROIC)	-26.47%	-4.73%	-39.71%	-16.91%	-8.36%	-42.16%	31.38%	63.04%	-1.14%	19.94%
Gross Margin	64%	66.48%	67.03%	63.99%	64.4%	54.81%	62.82%	66.53%	57.61%	58.44%
Net Margin	-2.31%	-2.34%	-18.02%	-7.65%	-6.24%	-71.38%	15.23%	54.44%	1.99%	15.9%
Debt / Equity	0.07x	-	0.19x	-	0.05x	0.06x	0.01x	0.02x	0.02x	0.01x
Interest Coverage	-12.44x	-16.61x	-53.97x	-12.80x	-	-588.14x	4120.00x	7415.50x	-	-
FCF Conversion	5.64x	2.46x	0.82x	4.23x	1.24x	0.06x	-0.07x	-0.06x	-4.42x	-0.13x
Revenue Growth	76.81%	44.17%	39%	28.36%	3.16%	-64.87%	182.36%	64.68%	-45.2%	71.31%

Revenue by Segment

	2018	2019	2020	2021	2022	2023	2024
Product	24.65M	25.11M	5.45M	23K	1.01M	20.35M	36.4M
Product Growth	-	1.86%	-78.30%	-99.58%	4313.04%	1904.63%	78.89%
Service Revenue	-	-	-	-	-	-	3.2M
Service Revenue Growth	-	-	-	-	-	-	-
Service	1.78M	2.15M	4.13M	3.11M	3.17M	2.8M	1.96M
Service Growth	-	21.28%	91.62%	-24.58%	1.96%	-11.88%	-29.89%
Product Revenue	-	-	-	-	-	-	247K
Product Revenue Growth	-	-	-	-	-	-	-

Revenue by Geography

	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	41.98M	22.28M	40.18M
UNITED STATES Growth	-	-	-	-	-	-46.92%	80.35%
CHINA	-	-	-	-	2.45M	1.49M	1.45M
CHINA Growth	-	-	-	-	-	-39.19%	-3.09%
ISRAEL	-	-	-	-	-	-	172K
ISRAEL Growth	-	-	-	-	-	-	-
Other	-	-	-	-	-	-	10K
Other Growth	-	-	-	-	-	-	-
GUATEMALA	-	-	-	-	-	190K	-
GUATEMALA Growth	-	-	-	-	-	-	-
IRELAND	-	-	-	-	-	135K	-
IRELAND Growth	-	-	-	-	-	-	-
Other Member	-	-	-	-	104K	45K	-
Other Member Growth	-	-	-	-	-	-56.73%	-

Frequently Asked Questions

Valuation & Price

Sensus Healthcare, Inc. (SRTS) has a price-to-earnings (P/E) ratio of 12.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Sensus Healthcare, Inc. (SRTS) reported $35.6M in revenue for fiscal year 2024. This represents a 513% increase from $5.8M in 2014.

Sensus Healthcare, Inc. (SRTS) grew revenue by 71.3% over the past year. This is strong growth.

Sensus Healthcare, Inc. (SRTS) reported a net loss of $3.0M for fiscal year 2024.

Dividend & Returns

Sensus Healthcare, Inc. (SRTS) has a return on equity (ROE) of 12.7%. This is reasonable for most industries.

Sensus Healthcare, Inc. (SRTS) had negative free cash flow of $0.1M in fiscal year 2024, likely due to heavy capital investments.